BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21831520)

  • 21. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST).
    Crusius JB; Canzian F; Capellá G; Peña AS; Pera G; Sala N; Agudo A; Rico F; Del Giudice G; Palli D; Plebani M; Boeing H; Bueno-de-Mesquita HB; Carneiro F; Pala V; Save VE; Vineis P; Tumino R; Panico S; Berglund G; Manjer J; Stenling R; Hallmans G; Martínez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Binghan S; Caldas C; Linseisen J; Kaaks R; Overvad K; Tjønneland A; Büchner FC; Peeters PH; Numans ME; Clavel-Chapelon F; Trichopoulou A; Lund E; Jenab M; Rinaldi S; Ferrari P; Riboli E; González CA
    Ann Oncol; 2008 Nov; 19(11):1894-902. PubMed ID: 18628242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
    Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
    Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study.
    Vineis P; Chuang SC; Vaissière T; Cuenin C; Ricceri F; ; Johansson M; Ueland P; Brennan P; Herceg Z
    Epigenetics; 2011 Feb; 6(2):195-201. PubMed ID: 20978370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Jenab M; Riboli E; Ferrari P; Sabate J; Slimani N; Norat T; Friesen M; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Touvier M; Boeing H; Schulz M; Linseisen J; Nagel G; Trichopoulou A; Naska A; Oikonomou E; Krogh V; Panico S; Masala G; Sacerdote C; Tumino R; Peeters PH; Numans ME; Bueno-de-Mesquita HB; Büchner FL; Lund E; Pera G; Sanchez CN; Sánchez MJ; Arriola L; Barricarte A; Quirós JR; Hallmans G; Stenling R; Berglund G; Bingham S; Khaw KT; Key T; Allen N; Carneiro F; Mahlke U; Del Giudice G; Palli D; Kaaks R; Gonzalez CA
    Carcinogenesis; 2006 Nov; 27(11):2250-7. PubMed ID: 16774936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk.
    Suzuki R; Yamamoto E; Nojima M; Maruyama R; Yamano HO; Yoshikawa K; Kimura T; Harada T; Ashida M; Niinuma T; Sato A; Nosho K; Yamamoto H; Kai M; Sugai T; Imai K; Suzuki H; Shinomura Y
    J Gastroenterol; 2014 Jul; 49(7):1135-44. PubMed ID: 23942619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes.
    Motoshita J; Oue N; Nakayama H; Kuraoka K; Aung PP; Taniyama K; Matsusaki K; Yasui W
    Cancer Sci; 2005 Aug; 96(8):474-9. PubMed ID: 16108828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.
    Wisnieski F; Santos LC; Calcagno DQ; Geraldis JC; Gigek CO; Anauate AC; Chen ES; Rasmussen LT; Payão SLM; Artigiani R; Demachki S; Assumpção PP; Lourenço LG; Arasaki CH; Pabinger S; Krainer J; Leal MF; Burbano RR; Arruda Cardoso Smith M
    J Mol Med (Berl); 2020 May; 98(5):707-717. PubMed ID: 32285140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
    Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
    PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
    Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
    Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Jenab M; McKay JD; Ferrari P; Biessy C; Laing S; Munar GM; Sala N; Peña S; Crusius JB; Overvad K; Jensen MK; Olsen A; Tjonneland A; Clavel-Chapelon F; Boutron-Ruault MC; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Georgila C; Psaltopoulou T; Mattiello A; Vineis P; Pala V; Palli D; Tumino R; Numans ME; Peeters PH; Bueno-de-Mesquita HB; Lund E; Ardanaz E; Sánchez MJ; Dorronsoro M; Sanchez CN; Quirós JR; Hallmans G; Stenling R; Manjer J; Régner S; Key T; Bingham S; Khaw KT; Slimani N; Rinaldi S; Boffetta P; Carneiro F; Riboli E; Gonzalez C
    Eur J Cancer; 2008 Apr; 44(6):774-80. PubMed ID: 18342503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
    Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
    Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
    Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
    Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.
    Sala N; Muñoz X; Travier N; Agudo A; Duell EJ; Moreno V; Overvad K; Tjonneland A; Boutron-Ruault MC; Clavel-Chapelon F; Canzian F; Kaaks R; Boeing H; Meidtner K; Trichopoulos A; Tsiotas K; Zylis D; Vineis P; Panico S; Palli D; Krogh V; Tumino R; Lund E; Bueno-de-Mesquita HB; Numans ME; Peeters PH; Quirós JR; Sánchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Hallmans G; Stenling R; Manjer J; Allen NE; Travis RC; Khaw KT; Jenab M; Offerhaus GJ; Riboli E; González CA
    Int J Cancer; 2012 May; 130(10):2417-27. PubMed ID: 21681742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.